1. Home
  2. EDAP vs PMVP Comparison

EDAP vs PMVP Comparison

Compare EDAP & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EDAP TMS S.A.

EDAP

EDAP TMS S.A.

HOLD

Current Price

$2.35

Market Cap

75.5M

Sector

Health Care

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.30

Market Cap

68.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDAP
PMVP
Founded
1979
2013
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.5M
68.9M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
EDAP
PMVP
Price
$2.35
$1.30
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$8.50
$5.00
AVG Volume (30 Days)
41.0K
236.5K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$74,853,925.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.61
N/A
52 Week Low
$1.21
$0.81
52 Week High
$3.05
$1.84

Technical Indicators

Market Signals
Indicator
EDAP
PMVP
Relative Strength Index (RSI) 57.56 42.33
Support Level $2.24 $1.23
Resistance Level $2.48 $1.36
Average True Range (ATR) 0.14 0.07
MACD 0.02 -0.01
Stochastic Oscillator 76.72 21.74

Price Performance

Historical Comparison
EDAP
PMVP

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Share on Social Networks: